In the medulloblastoma cohort, association between CTNNB1 nuclear immunoreactivity and percentage of cases that had relapsed almost reached significance (Fisher's exact test, P=0.056) with a lower percentage of relapses seen in the nuclear cases. Here, CTNNB1 is linked to medulloblastoma.